Peninsula Pharmaceuticals

Peninsula Pharmaceuticals

Focused on development and commercialization of antibiotics

Human health & social work | Northern America | Health Improvement |

 

Overview

Peninsula was acquired by Johnson & Johnson on June 30th 2005. Peninsula is a biopharmaceutical company focused on the development and commercialization of antibiotics to treat life threatening infections. The Company s mission is to develop optimal anti infective therapies that offer improved efficacy dosing and safety characteristics over existing therapies. In addition to DBL Investors investors include Canaan Partners and Domain Associates.

Industry

Legal Structure

Operating Status

Employees

Human health & social work Operating

Funding and Financing Rounds


Team


Impact

Geographies:

Social Objectives:

Environmental Objectives:

Operational Impact:


Impact Reports & Metrics


Offices

Peninsula Pharmaceuticals

1751 Harbor Bay Parkway
Alameda, California 94502
United States of America



Explore

Revision History


Quick Search



  • Global  
  • Africa  
  • Americas  
  • Asia  
  • Europe  
  • Oceania  


Incoming

Tags

COPYRIGHT 2017 IMPACTSPACE. ALL RIGHTS RESERVED.